04 April 2025 Press releases

GvW advises osapiens on the acquisition of BYRD Health

GvW Graf von Westphalen advised osapiens, the leading software platform for sustainable growth and ESG compliance, on the acquisition of BYRD Health. The transaction strengthens the strategic partnership between osapiens and the trade and services group Markant and its subsidiary BAYARD.

BYRD Health, previously a division of Markant subsidiary BAYARD GmbH, is one of the leading providers of master data management in the medical technology sector. BYRD Health's solutions enable companies to comply with international UDI regulations such as EUDAMED, GUDID, and TGA, as well as standardized product data management. The integration into osapiens will expand the existing services with additional AI-supported solutions in the area of product compliance.

osapiens is a technology company founded in 2018 and headquartered in Mannheim, Germany, that develops sustainability and efficiency software solutions for more than 1,900 customers worldwide. With its “osapiens HUB” platform, the company supports the implementation of regulatory requirements such as CSRD, EUDR, and LkSG. Last year, the long-standing GvW client completed a US$120 million financing round led by Growth Equity at Goldman Sachs Alternatives (more).

The GvW team consisted of Titus Walek and Alexander Metz (both M&A) as well as Dr Joachim Mulch (IP) and Karsten Kujath (Labor Law), Dr Gerd Schwendinger and Roman Jusen (both Foreign Investment Control).

Stay informed

You don't want to miss any more of the latest legal developments? And be invited to our events? Then register here.